TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24800335

Group type: EXPERIMENTAL
Intervention: Clean Intermittent Self Catheterisation (CISC) performed by inserting a Classic Neleton Catheter (No. 16 or 18) twice a day for 1 week, then once a day for another 4 weeks and then once weekly continued for one year.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Internal Optical Urethrotomy (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clean Intermittent Self Catheterisation (CISC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no CISC)
Number of subjects: 60
Study: 19802806

Group type: EXPERIMENTAL
Intervention: Very-low-protein diet (VLpD)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Low-protein diet (LpD)
Number of subjects: 32
Study: 17355489

Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg per day
Number of subjects: 756

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 756
Study: 15254052

Group type: EXPERIMENTAL
Intervention: Irinotecan 100 mg/m² weekly for 4 weeks followed by a 2-week rest (weekly arm)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Irinotecan 240 mg/m² every 3 weeks (every‐3‐weeks arm)
Number of subjects: 103
Study: 11536090

Group type: EXPERIMENTAL
Intervention: Bone-patellar tendon-bone with interference screw fixation (Group A)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Bone-patellar tendon-bone with transcondylar screw fixation (Group B)
Number of subjects: 55
Study: 9564110

Group type: EXPERIMENTAL
Intervention: Serum
Number of subjects: 189

Group type: COMPARATOR
Intervention: Plasmanate
Number of subjects: 189
Study: 7812416

Group type: EXPERIMENTAL
Intervention: Total body water estimation of body fat
Number of subjects: 35

Group type: COMPARATOR
Intervention: Underwater weight estimation of body fat
Number of subjects: 35
Study: 3378905

Group type: EXPERIMENTAL
Intervention: 14-week training program on personal health skills
Number of subjects: 88
Study: 28960663

Group type: EXPERIMENTAL
Intervention: High-dose transdermal nicotine (90 mg/day)
Number of subjects: 40
Study: 28944715

Group type: EXPERIMENTAL
Intervention: Balance training
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (regular activity schedule)
Number of subjects: 26
Study: 25913046

Group type: EXPERIMENTAL
Intervention: Hypotonic solution (Na 30 mEq/L NaCl or 0.18%)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isotonic solution (Na 150 mEq/L or 0.9% NaCl)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both isotonic and hypotonic solutions
Number of subjects: 50
Study: 23937999

Group type: EXPERIMENTAL
Intervention: Paracetamol (acetaminophen)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20653455

Group type: EXPERIMENTAL
Intervention: Both medications at bedtime (valsartan 160 mg/day and amlodipine 5 mg/day)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Both medications on awakening (valsartan 160 mg/day and amlodipine 5 mg/day)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Valsartan on awakening and amlodipine at bedtime
Number of subjects: 203

Group type: COMPARATOR
Intervention: Valsartan at bedtime and amlodipine on awakening
Number of subjects: 203
Study: 18422825

Group type: EXPERIMENTAL
Intervention: Intervention practices promoting alcohol screening and brief counseling
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control practices
Number of subjects: 21
Study: 16997056

Group type: EXPERIMENTAL
Intervention: Gentamicin/citrate (4 mg/mL)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Minocycline/EDTA
Number of subjects: 62

Group type: COMPARATOR
Intervention: Heparin (control)
Number of subjects: 62
Study: 12677265

Group type: EXPERIMENTAL
Intervention: Laparoscopic gastric banding
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Weight loss greater than 1.7% per week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal-weight volunteers (control group)
Number of subjects: 40
Study: 10872960

Group type: EXPERIMENTAL
Intervention: Curved bristle toothbrush
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional straight bristle toothbrush
Number of subjects: 100
Study: 9541997

Group type: EXPERIMENTAL
Intervention: Breast milk from Russian women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breast milk from Vietnamese women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breast milk from both Vietnamese and Russian women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation of food components and toxic compounds
Number of subjects: 0
Study: 8173923

Group type: EXPERIMENTAL
Intervention: Dopamine infusion at 3 micrograms kg‐1 min‐1 for 48 hours after surgery
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group receiving 3 litres 5% dextrose and bolus of intravenous frusemide 1 mg kg‐1
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both groups (dopamine and control)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Dopamine infusion
Number of subjects: 23
Study: 2852111

Group type: EXPERIMENTAL
Intervention: Calciparine (15,000 IU day‐1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fragmin (5000 anti‐Xa U/d)
Number of subjects: 80
Study: 29802770

Group type: EXPERIMENTAL
Intervention: Bilateral, preconversation, communication-priming intervention (Jumpstart-Tips)
Number of subjects: 537

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 537
Study: 28833428

Group type: EXPERIMENTAL
Intervention: Feedback containing normative comparisons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feedback reports including lists of clinical presentations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feedback reports containing information in combination with response certitude
Number of subjects: 0

Group type: COMPARATOR
Intervention: General feedback (not specified)
Number of subjects: 0
Study: 25625938

Group type: EXPERIMENTAL
Intervention: D3P (docetaxel: 75 mg/m2, intravenous infusion, every three weeks; Prednisone 10mg orally daily)
Number of subjects: 228

Group type: COMPARATOR
Intervention: M3P (mitoxantrone: 12 mg/m2, intravenous infusion, every three weeks; Prednisone 10mg orally daily)
Number of subjects: 228
Study: 23553700

Group type: EXPERIMENTAL
Intervention: END anti-stigma programme (intervention group)
Number of subjects: 1452

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1452
Study: 21208227

Group type: EXPERIMENTAL
Intervention: Optimal sensed AV delay of 129 ± 19 ms during Sinus rhythm
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Optimal paced AV delay of 175 ± 24 ms during atrial pacing
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: P-wave duration (PWd) during Sinus rhythm
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: RA-RV interval during Sinus rhythm
Number of subjects: 33
Study: 18806198

Group type: EXPERIMENTAL
Intervention: Qualitative research methods applied to improve recruitment rates in RCTs
Number of subjects: 0

Group type: COMPARATOR
Intervention: ProtecT study's complex intervention
Number of subjects: 0
Study: 16937176

Group type: EXPERIMENTAL
Intervention: Water environment (32 degrees C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Air environment
Number of subjects: 10
Study: 12725963

Group type: EXPERIMENTAL
Intervention: Automated data extraction system for ECG
Number of subjects: 0
Study: 10849573

Group type: EXPERIMENTAL
Intervention: Obese children (BMI > 95th percentile)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Non-obese children (10th percentile < BMI > 90th percentile)
Number of subjects: 124
Study: 9014663

Group type: EXPERIMENTAL
Intervention: Laparoscopic ultrasonography with adapted urethral probe
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Laparoscopic ultrasonography with specialized laparoscopic probe
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intraoperative cholangiography
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Laparoscopic ultrasonography
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Laparoscopic ultrasonography with specialized probe
Number of subjects: 200
Study: 1396621

Group type: EXPERIMENTAL
Intervention: Tetracycline (250 mg for children, 500 mg for adults)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Procaine penicillin (200,000 units for children, 600,000 IU for adults)
Number of subjects: 120
Study: 3530366

Group type: EXPERIMENTAL
Intervention: Coumarin treatment
Number of subjects: 71

Group type: COMPARATOR
Intervention: No anticoagulant treatment (Control)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Coumarin treatment (in limb salvage surgery)
Number of subjects: 71

Group type: COMPARATOR
Intervention: No anticoagulant treatment (Control, in limb salvage surgery)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Overall results for limb salvage surgery
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Overall results for stages II and II-III
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Site of distal anastomosis (above knee)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Site of distal anastomosis (below knee)
Number of subjects: 71
Study: 31750598

Group type: EXPERIMENTAL
Intervention: Nurse case management (NCM)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 68
Study: 28718987

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 10
Study: 27161812

Group type: EXPERIMENTAL
Intervention: Inquiry-based peer-assisted learning project (bioinformatics module)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pre- and post-module quizzes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative assessment via post-module surveys
Number of subjects: 0
Study: 25009197

Group type: EXPERIMENTAL
Intervention: Propofol general anaesthesia with paravertebral analgesia (PPA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard sevoflurane general anaesthesia with opioid analgesia (SGA)
Number of subjects: 20
Study: 24047007

Group type: EXPERIMENTAL
Intervention: Trans-septal suture (Group A)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Intranasal pack (Group B)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study: 20526911

Group type: EXPERIMENTAL
Intervention: Physician estimates of calcium intake
Number of subjects: 97

Group type: COMPARATOR
Intervention: Short Calcium Questionnaire (SCQ)
Number of subjects: 97
Study: 18545201

Group type: EXPERIMENTAL
Intervention: Supplemental carbohydrate (CHO) ingestion (0.3g.kgCHO.bodymass)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PLC) of equal volume
Number of subjects: 8
Study: 15941890

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (50-800 microg/d)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 308
Study: 12697487

Group type: EXPERIMENTAL
Intervention: Itraconazole treatment group
Number of subjects: 114
Study: 10432616

Group type: EXPERIMENTAL
Intervention: Ethanol consumption (approximately 0.3 g/kg) as beer, white wine, or vodka mixed with orange juice
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Abdominal compression belt applied to provoke gastroesophageal reflux
Number of subjects: 10
Study: 8520505

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HDC) and total body irradiation (TBI) followed with autologous blood stem cell transplantation (ABSCT)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Conventional vincristine, melphalan, cyclophosphamide and prednisone (VMCP) regimen
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Overall survival for all patients
Number of subjects: 167
Study: 1722692

Group type: EXPERIMENTAL
Intervention: Mu‐cron tablets (phenylpropanolamine 50 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Boots Cold Relief tablets (phenylephrine 10 mg and caffeine 60 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Boots Pain Relief tablets (caffeine 60 mg)
Number of subjects: 16
Study: 6460717

Group type: EXPERIMENTAL
Intervention: Imipramine at 75 mg/day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Zimelidine at 100 mg/day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Zimelidine at 200 mg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Imipramine at 25 mg three times daily
Number of subjects: 20
Study: 31482197

Group type: EXPERIMENTAL
Intervention: tRNS (1 mA for 10 min)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 140 Hz tACS (1 mA for 10 min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation (10 min)
Number of subjects: 30
Study: 28994033

Group type: EXPERIMENTAL
Intervention: High-fidelity simulator (HFS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Low-fidelity simulator (LFS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Overall improvement
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Total improvement
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Postgraduate year
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Specialty
Number of subjects: 36
Study: 25882474

Group type: EXPERIMENTAL
Intervention: Head vibration
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Mental distraction
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combined effect of head vibration and mental distraction
Number of subjects: 18
Study: 24314888

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 or 120 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22545079

Group type: EXPERIMENTAL
Intervention: Laboratory and clinical monitoring (LCM)
Number of subjects: 3316

Group type: COMPARATOR
Intervention: Clinically-driven monitoring (CDM)
Number of subjects: 3316

Group type: COMPARATOR
Intervention: Routine toxicity monitoring
Number of subjects: 3316

Group type: EXPERIMENTAL
Intervention: Routine 12-weekly CD4 monitoring from year 2 on ART
Number of subjects: 3316
Study: 20069805

Group type: EXPERIMENTAL
Intervention: Osteoporosis educational intervention
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 105
Study: 17440203

Group type: EXPERIMENTAL
Intervention: Emotion expressions resembling babies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotion expressions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Objective indices of babyfaceness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attractiveness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Happy expressions
Number of subjects: 0
Study: 15244106

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Anaerobic exercise
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 18
Study: 12397189

Group type: EXPERIMENTAL
Intervention: Subtotal abdominal hysterectomy
Number of subjects: 279

Group type: COMPARATOR
Intervention: Total abdominal hysterectomy
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 279
Study: 9667165

Group type: EXPERIMENTAL
Intervention: Desensitizing agents (specific agents not detailed)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 7855203

Group type: EXPERIMENTAL
Intervention: Pentagastrin (0.1, 0.3, and 0.6 microgram/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 30
Study: 2671289

Group type: EXPERIMENTAL
Intervention: Carboplatin (CBDCA) plus Methotrexate (MTX) - CBDCA administered IV monthly at doses of 400 mg/m2, MTX given IV weekly at doses of 40 mg/m2.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Methotrexate (MTX) alone - administered IV weekly at doses of 40 mg/m2.
Number of subjects: 40
Study: 335903

Group type: EXPERIMENTAL
Intervention: Naloxone hydrochloride (intravenous administration)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31984514

Group type: EXPERIMENTAL
Intervention: Alcohol beverage
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Placebo beverage
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Told-no-alcohol beverage
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control (no alcohol)
Number of subjects: 165
Study: 31184783

Group type: EXPERIMENTAL
Intervention: Experimental intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 0
Study: 28917376

Group type: EXPERIMENTAL
Intervention: Ayurvedic nutritional counseling
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional nutritional counseling
Number of subjects: 34
Study: 25694417

Group type: EXPERIMENTAL
Intervention: Lapatinib plus capecitabine (LAP+CAP) 1250mg/day and 2000mg/m² on days 1-14 of a 21-day cycle
Number of subjects: 37

Group type: COMPARATOR
Intervention: Lapatinib (LAP) 1500mg monotherapy on days 1-21
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Lapatinib plus capecitabine (LAP+CAP)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Lapatinib (LAP)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Lapatinib (LAP) and Lapatinib plus capecitabine (LAP+CAP)
Number of subjects: 37
Study: 23107074

Group type: EXPERIMENTAL
Intervention: Thulium laser resection of the prostate (TMLRP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bipolar transurethral plasmakinetic prostatectomy (TUPKP)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Comparison of TMLRP and TUPKP
Number of subjects: 100
Study: 21622028

Group type: EXPERIMENTAL
Intervention: Supervised exercise
Number of subjects: 301

Group type: COMPARATOR
Intervention: Chiropractic spinal manipulation
Number of subjects: 301

Group type: COMPARATOR
Intervention: Home exercise
Number of subjects: 301
Study: 20128352

Group type: EXPERIMENTAL
Intervention: Group MAP (antimalarial, retinol supplement, and anti-parasitic drug)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Group MA (antimalarial and retinol supplement)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Group MP (antimalarial and anti-parasitic drug)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Group M (treatment only with antimalarials)
Number of subjects: 93
Study: 16956456

Group type: EXPERIMENTAL
Intervention: TEA-PEG-3 cocamide sulfate
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: CAPB
Number of subjects: 22
Study: 12723459

Group type: EXPERIMENTAL
Intervention: Intravenous dichloroacetate (DCA) 50 mg/kg
Number of subjects: 124
Study: 10757193

Group type: EXPERIMENTAL
Intervention: Oxandrolone 20 mg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo 20 mg/day
Number of subjects: 20
Study: 9032632

Group type: EXPERIMENTAL
Intervention: Air Flushing Clean System (AFCS) without dental vacuum suction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Air Flushing Clean System (AFCS) with dental vacuum suction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional handpiece
Number of subjects: 0
Study: 8486815

Group type: EXPERIMENTAL
Intervention: Triazolam (8 micrograms/kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ethanol (1.0 g/kg)
Number of subjects: 8
Study: 3087488

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg twice daily)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 29425372

Group type: EXPERIMENTAL
Intervention: Partial sleep deprivation (PSD) for five nights with maximum 4 hours of sleep per night.
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Prolonged period of PSD for eight nights with 4 hours of sleep per night.
Number of subjects: 13

Group type: COMPARATOR
Intervention: Baseline sleep period with five nights of 8 hours spent in bed.
Number of subjects: 13
Study: 27462009

Group type: EXPERIMENTAL
Intervention: SMC021 (0.8 mg/d)
Number of subjects: 4665

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4665

Group type: EXPERIMENTAL
Intervention: SMC021
Number of subjects: 4665
Study: 25354769

Group type: EXPERIMENTAL
Intervention: Mechanochemical endovenous ablation (MOCA™)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 160
Study: 22677763

Group type: EXPERIMENTAL
Intervention: Cereton (4 ml, 1000 mg intravenously for 10 days) in combination with traditional treatment
Number of subjects: 95

Group type: COMPARATOR
Intervention: Traditional treatment only
Number of subjects: 95
Study: 20453679

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH), 0.075 mg x kg(‐1) x day(‐1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Corticosteroids (CTX) alone
Number of subjects: 20
Study: 17506156

Group type: EXPERIMENTAL
Intervention: Nicotine + 6 mg mecamylamine
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Nicotine + 3 mg mecamylamine
Number of subjects: 540

Group type: COMPARATOR
Intervention: Nicotine only
Number of subjects: 540
Study: 16388991

Group type: EXPERIMENTAL
Intervention: Randomized consent designs (incomplete-double-consent)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Randomized consent designs (single-consent)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Randomized consent designs (complete-double-consent)
Number of subjects: 50
Study: 13129459

Group type: EXPERIMENTAL
Intervention: Fe alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fe with other haematinics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups (including placebo)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fe alone and Fe with other haematinics
Number of subjects: 0
Study: 10823019

Group type: EXPERIMENTAL
Intervention: Written intervention (informing physicians about their own average and the group average)
Number of subjects: 11

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 11
Study: 9255000

Group type: EXPERIMENTAL
Intervention: Intratumoural chlorpromazine (CPZ) with hypofractionated external radiation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Radiation alone (Control)
Number of subjects: 43